We analyzed treatment and outcome in 104 Scandinavian patients with synovial sarcoma in the extremities or trunk wall, diagnosed between 1986 and 1994. Only surgically treated patients without metastases at diagnosis were included. Median follow-up of survivors was 6 (3-11) years. 34 patients developed metastases. The overall 5- and 7-year survival rates were 0.76 (95% Cl 0.66-0.83) and 0.69 (0.58-0.78), respectively. Large tumor size and amputation were significantly associated with impaired metastasis-free survival. Patients with local recurrence had a higher risk of metastases following the local event. Local excision with inadequate margin was associated with a higher risk of local recurrence
Background: Synovial sarcoma is a high grade sarcoma that usually occurs in adults. Numerous studies...
Background: Synovial sarcoma (SS) is part of soft tissue sarcomas (STS). An incidence between 5% to ...
International audienceBackground: Synovial sarcoma (SS) occurs in both adult and pediatric patients....
We analyzed treatment and outcome in 104 Scandinavian patients with synovial sarcoma in the extremit...
BACKGROUND: The optimal treatment for synovial sarcoma remains controversial. Treatment, outcome, an...
Introduction: Synovial sarcoma (SS) is a malignant mesenchymal tumor. It is most common among childr...
Synovial sarcoma accounts for 5 to 10 % of all soft tissue sarcomas. More than 90 % are found in the...
Synovial sarcoma is malignant soft tissue tumor which is the most prevalent in adolescents and young...
Introduction Synovial sarcoma accounts for 5% to 10% of malignant soft-tissue tumours. It occurs mor...
BACKGROUND: Prognostic factors for localized synovial sarcoma are well defined. However, few data ex...
Background: We aimed to evaluate prognostic factors and response rates to various treatment approach...
In SS, metastases develop late with high mortality. Patients with SS should be followed for >10 year
Background: Synovial sarcoma (SS) is a malignant soft tissue sarcoma with a poor prognosis because o...
BACKGROUND Synovial sarcoma of the foot/ankle is rare. Mutilating surgery is often discussed. METH...
Background: Synovial sarcoma is a high grade sarcoma that usually occurs in adults. Numerous studies...
Background: Synovial sarcoma (SS) is part of soft tissue sarcomas (STS). An incidence between 5% to ...
International audienceBackground: Synovial sarcoma (SS) occurs in both adult and pediatric patients....
We analyzed treatment and outcome in 104 Scandinavian patients with synovial sarcoma in the extremit...
BACKGROUND: The optimal treatment for synovial sarcoma remains controversial. Treatment, outcome, an...
Introduction: Synovial sarcoma (SS) is a malignant mesenchymal tumor. It is most common among childr...
Synovial sarcoma accounts for 5 to 10 % of all soft tissue sarcomas. More than 90 % are found in the...
Synovial sarcoma is malignant soft tissue tumor which is the most prevalent in adolescents and young...
Introduction Synovial sarcoma accounts for 5% to 10% of malignant soft-tissue tumours. It occurs mor...
BACKGROUND: Prognostic factors for localized synovial sarcoma are well defined. However, few data ex...
Background: We aimed to evaluate prognostic factors and response rates to various treatment approach...
In SS, metastases develop late with high mortality. Patients with SS should be followed for >10 year
Background: Synovial sarcoma (SS) is a malignant soft tissue sarcoma with a poor prognosis because o...
BACKGROUND Synovial sarcoma of the foot/ankle is rare. Mutilating surgery is often discussed. METH...
Background: Synovial sarcoma is a high grade sarcoma that usually occurs in adults. Numerous studies...
Background: Synovial sarcoma (SS) is part of soft tissue sarcomas (STS). An incidence between 5% to ...
International audienceBackground: Synovial sarcoma (SS) occurs in both adult and pediatric patients....